Canadian genetic healthcare professionals’ attitudes towards discussing private pay options with patients
Sign Up to like & getrecommendations! Published in 2019 at "Molecular Genetics & Genomic Medicine"
DOI: 10.1002/mgg3.572
Abstract: Just as there is inconsistency with respect to coverage of genomic testing with insurance carriers, there is interprovincial discrepancy in Canada. Consequently, the option of private pay (e.g., self pay) arises, which can lead to… read more here.
Keywords: pay; private pay; options patients; pay options ... See more keywords
The pharmacotherapeutic options in patients with catecholamine-resistant vasodilatory shock
Sign Up to like & getrecommendations! Published in 2022 at "Expert Review of Clinical Pharmacology"
DOI: 10.1080/17512433.2022.2110067
Abstract: ABSTRACT Introduction Septic and vasoplegic shock are common types of vasodilatory shock (VS) with high mortality. After fluid resuscitation and the use of catecholamine-mediated vasopressors (CMV), vasopressin, angiotensin II, methylene blue (MB), and hydroxocobalamin can… read more here.
Keywords: pharmacotherapeutic options; options patients; catecholamine resistant; vasodilatory shock ... See more keywords
Targeted Therapies: Treatment Options for Patients With Metastatic Breast Cancer.
Sign Up to like & getrecommendations! Published in 2019 at "Clinical journal of oncology nursing"
DOI: 10.1188/19.cjon.434-438
Abstract: Standard therapies for treating hormone-sensitive metastatic breast cancer (BC) include the blockage of estrogen pathways by using selective estrogen modulator receptors or selective estrogen receptor downregulators and by using aromatase inhibitors to block estrogen production.… read more here.
Keywords: metastatic breast; targeted therapies; breast cancer; treatment options ... See more keywords
Therapeutic Options for Patients with TP53 Deficient Chronic Lymphocytic Leukemia: Narrative Review
Sign Up to like & getrecommendations! Published in 2021 at "Cancer Management and Research"
DOI: 10.2147/cmar.s283903
Abstract: Abstract Chronic lymphocytic leukemia (CLL), which is the most common type of leukemia in western countries in adults, is characterized by heterogeneity in clinical course, prognosis and response to the treatment. Although, in recent years… read more here.
Keywords: leukemia; chronic lymphocytic; therapeutic options; lymphocytic leukemia ... See more keywords